Literature DB >> 3014468

Worldwide experience with the Oka-strain live varicella vaccine.

F E Andre.   

Abstract

Sufficient safety and efficacy data have been obtained on a live varicella vaccine (Varilrix, Smith Kline-RIT) derived from the Oka-strain attenuated varicella-zoster virus to justify its recent licensure in several European countries for use in special indication groups. This review article summarizes the data obtained in Japan, Europe, and the United States. In addition, a survey of the published literature on clinical studies performed on as yet unlicensed Oka-strain varicella vaccines produced by the Biken Institute and Merck Sharp & Dohme is presented.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3014468

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

1.  The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster.

Authors:  G P Garnett; B T Grenfell
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

Review 2.  Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.

Authors:  Arnaud G L'Huillier; Deepali Kumar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Should children in renal failure be immunised against chickenpox before receiving a renal transplant.

Authors:  R B Heath
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

4.  Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children.

Authors:  A Y Tan; C J Connett; G J Connett; S C Quek; H K Yap; F Meurice; B W Lee
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

5.  Clinical experience of Oka-strain live varicella vaccine.

Authors:  H Kamiya; T Ihara
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

6.  Impact and costs of varicella prevention in a university hospital.

Authors:  D J Weber; W A Rutala; C Parham
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

7.  The use of varicella vaccine in Britain.

Authors:  H O Kangro; R B Heath
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-23

8.  Immunisation against chickenpox. Good argument exists for universal vaccination.

Authors:  G R Skinner; J Davies
Journal:  BMJ       Date:  1995-04-01

9.  Efficacy of varicella vaccine in patients with solid tumours.

Authors:  R B Heath; J S Malpas; H O Kangro; A Ward; J M McEniery; J E Kingston
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

10.  Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus.

Authors:  J Davies; J A Hallworth; P McLeish; S Randall; B A Martin; A Buchan; G R Skinner
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.